Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-001190
Filing Date
2021-02-01
Accepted
2021-02-01 07:30:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28746
2 filename2.txt TEXT-EXTRACT 2918
  Complete submission text file 0000000000-21-001190.txt   43236
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filed for) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations